These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29356263)

  • 1. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - reply.
    Schreglmann SR; Büchele F; Kägi G; Baumann CR;
    Eur J Neurol; 2018 Feb; 25(2):e27-e28. PubMed ID: 29356263
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on: 'Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial'.
    Simões RM; Castro Caldas A; Ferreira JJ
    Eur J Neurol; 2018 Jan; 25(1):e4. PubMed ID: 29271586
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
    Schreglmann SR; Büchele F; Sommerauer M; Epprecht L; Kägi G; Hägele-Link S; Götze O; Zimmerli L; Waldvogel D; Baumann CR
    Eur J Neurol; 2017 Apr; 24(4):545-551. PubMed ID: 28224720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyridostigmine in the treatment of primary orthostatic hypotension].
    Monge Argiles JA; Leiva Santana C
    Neurologia; 2007 May; 22(4):260-2. PubMed ID: 17492522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory 24-hour blood pressure recordings in patients with Parkinson's disease with or without fludrocortisone.
    Hakamäki T; Rajala T; Lehtonen A
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):367-9. PubMed ID: 9707350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridostigmine in the treatment of orthostatic intolerance.
    Gales BJ; Gales MA
    Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension.
    Singer W; Opfer-Gehrking TL; McPhee BR; Hilz MJ; Bharucha AE; Low PA
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1294-8. PubMed ID: 12933939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study.
    Sandroni P; Opfer-Gehrking TL; Singer W; Low PA
    Clin Auton Res; 2005 Feb; 15(1):51-3. PubMed ID: 15768203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment counters low blood pressure upon standing.
    Mayo Clin Health Lett; 2005 Apr; 23(4):4. PubMed ID: 15864838
    [No Abstract]   [Full Text] [Related]  

  • 10. Acetylcholinesterase inhibition and orthostatic hypotension.
    Provitera V; Nolano M; Pagano A
    Clin Auton Res; 2006 Apr; 16(2):136. PubMed ID: 16572351
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease.
    Schoffer KL; Henderson RD; O'Maley K; O'Sullivan JD
    Mov Disord; 2007 Aug; 22(11):1543-9. PubMed ID: 17557339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
    Singer W; Sandroni P; Opfer-Gehrking TL; Suarez GA; Klein CM; Hines S; O'Brien PC; Slezak J; Low PA
    Arch Neurol; 2006 Apr; 63(4):513-8. PubMed ID: 16476804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholinesterase inhibition in the treatment of hypotension.
    Schondorf R
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1187. PubMed ID: 12933916
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyridostigmine in autonomic failure: can we treat postural hypotension and bladder dysfunction with one drug?
    Yamamoto T; Sakakibara R; Yamanaka Y; Uchiyama T; Asahina M; Liu Z; Ito T; Koyama Y; Awa Y; Yamamoto K; Kinou M; Hattori T
    Clin Auton Res; 2006 Aug; 16(4):296-8. PubMed ID: 16862395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholinesterase inhibition in patients with orthostatic intolerance.
    Singer W; Opfer-Gehrking TL; Nickander KK; Hines SM; Low PA
    J Clin Neurophysiol; 2006 Oct; 23(5):476-81. PubMed ID: 17016160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of orthostatic hypotension in Parkinson's disease: from pathophysiology to management.
    Pathak A; Senard JM
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):393-403. PubMed ID: 15151485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridostigmine in the treatment of orthostatic hypotension.
    Senard JM
    Clin Auton Res; 2005 Dec; 15(6):421-2; author reply 423. PubMed ID: 16362550
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased baroreflex sensitivity in Parkinson's disease is associated with orthostatic hypotension.
    Blaho A; Šutovský S; Valkovič P; Šiarnik P; Sýkora M; Turčáni P
    J Neurol Sci; 2017 Jun; 377():207-211. PubMed ID: 28477697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual wires and autonomic failure treatment.
    Jordan J
    Clin Auton Res; 2006 Jun; 16(3):200-1. PubMed ID: 16871652
    [No Abstract]   [Full Text] [Related]  

  • 20. Atomoxetine for Orthostatic Hypotension in an Elderly Patient Over 10 Weeks: A Case Report.
    Hale GM; Brenner M
    Pharmacotherapy; 2015 Sep; 35(9):e141-8. PubMed ID: 26406777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.